Curcumin implants for continuous systemic delivery: safety and biocompatibility.
about
Controlled-release systemic delivery - a new concept in cancer chemoprevention.Controlled systemic delivery by polymeric implants enhances tissue and plasma curcumin levels compared with oral administration.Curcumin implants, not curcumin diet, inhibit estrogen-induced mammary carcinogenesis in ACI rats.Bioavailability of phytochemicals and its enhancement by drug delivery systems.Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health.Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus
P2860
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@en
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@nl
type
label
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@en
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@nl
prefLabel
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@en
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@nl
P2093
P2860
P1476
Curcumin implants for continuous systemic delivery: safety and biocompatibility.
@en
P2093
Farrukh Aqil
Hina Kausar
Jeyaprakash Jeyabalan
Manicka V Vadhanam
Ramesh C Gupta
Shyam S Bansal
Srivani Ravoori
P2860
P2888
P304
P356
10.1007/S13346-011-0028-0
P577
2011-08-01T00:00:00Z